Predonation of autologous blood reduces perioperative allogenic transfusion requirement in grown-up patients with congenital heart disease.

[1]  Y. Takami,et al.  Predictors of allogenic blood transfusion in elective cardiac surgery after preoperative autologous blood donation , 2009, Surgery Today.

[2]  Neil Blumberg,et al.  The platelet as an immune cell—CD40 ligand and transfusion immunomodulation , 2009, Immunologic research.

[3]  W. Hoffmann,et al.  Impact of demographic changes on the blood supply: Mecklenburg‐West Pomerania as a model region for Europe , 2007, Transfusion.

[4]  B. Bierbaum,et al.  Autologous blood donation and subsequent blood use in patients undergoing total knee arthroplasty , 2006, Transfusion medicine.

[5]  L. Hiratzka,et al.  Autologous Blood Transfusion in Elective Cardiac Valve Operations , 2005, Journal of cardiac surgery.

[6]  W. Dietrich,et al.  Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness. , 2005, Journal of Cardiothoracic and Vascular Anesthesia.

[7]  I. Jovin,et al.  Post-operative course of coronary artery bypass surgery patients who pre-donate autologous blood. , 2003, International journal of cardiology.

[8]  J. Somerville.  Grown-Up Congenital Heart Disease-Medical Demands Look Back, Look Forward 2000* , 2001, The Thoracic and cardiovascular surgeon.

[9]  H. Eichler,et al.  Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. , 2000, Blood.

[10]  J. Hess,et al.  Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. , 1999, Clinical pediatrics.

[11]  E. Vamvakas,et al.  Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells , 1999, Transfusion.

[12]  D. Glancy,et al.  Cardiac surgery for grown-up congenital heart patients: survey of 307 consecutive operations from 1991 to 1994. , 1997, The American journal of cardiology.

[13]  N. Blumberg,et al.  Allogeneic transfusion and infection: economic and clinical implications. , 1997, Seminars in hematology.

[14]  J. Perloff.  Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements, renal function, and urate metabolism. , 1993, Cardiology clinics.

[15]  B. Noble,et al.  Blood management in total knee arthroplasty: a comparison of techniques. , 2009, Orthopedics.

[16]  A. Rueda.  Rethinking blood shield statutes in view of the hepatitis C pandemic and other emerging threats to the blood supply. , 2001, Journal of health law.